Background: Dasatinib is a tyrosine kinase inhibitor commonly used as first-line treatment for chronic myeloid leukemia (CML). Although pulmonary complications are uncommon, dasatinib has been associated with serious adverse effects, including pulmonary arterial hypertension (PAH). Dasatinib-related PAH is currently ca...
Ö. Kümet, Remzi Sarıkaya· Research in Heart Yield and...· 0 citations
BACKGROUND
The atherogenic index of plasma (AIP) and inflammatory indices may reflect the burden of atherosclerosis. This study evaluated their predictive value for obstructive coronary artery disease (CAD) in patients with non-ST-elevation myocardial infarction (NSTEMI).
METHODS
This retrospective study included 624...
Veysi Can, Fuat Polat, A. Kaya et al.· Acta Clinica Belgica· 0 citations
Background: Chronic coronary syndrome (CCS) remains a major cause of morbidity and mortality worldwide, and real-world data on outpatient management are limited. Methods: In total, 697 patients with previously diagnosed CCS who visited outpatient cardiology clinics at 25 centers in Turkey between June 2023 and December...
Abdulla Arslan, O. G. Ozkaya, Fatih Aytemiz et al.· Journal of Cardiovascular De...· 0 citations
Although the AUC indicates moderate discriminative performance, regional strain analysis may serve as an adjunctive risk stratification tool alongside LVEF in this population, and may help identify patients who warrant further evaluation with advanced imaging modalities.
Ö. Kümet, F. Şaylık, T. Akbulut et al.· SN Comprehensive Clinical Me...· 0 citations
Benidipine therapy was associated with significant BP reduction and clinically meaningful improvement in angina-related health status over 3 months, and this findings should be interpreted within the limitations of an observational study and warrant confirmation in controlled comparative studies.
Ayşegül Ülgen Kunak, T. Kunak, Ertan Aydın et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.